Also, stage pT1 of HCC, bigger tumor size, higher mean CD8+ density in the non-malignant region, wider tumor-free margin, and shorter time of surgery are associated with shorter regression‐free survival (110). This evidence concerns the gene CD8A and hepatocellular carcinoma.